Last updated on April 2019

A Phase 3 Study to Evaluate the Efficacy and Safety of TNX-102 SL in Participants With PTSD


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Post-Traumatic Stress Disorder
  • Age: Between 18 - 75 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Male and Female subjects between the years of 18-75 with a diagnosis of PTSD (diagnosis can be made at screening)
  • Index trauma must have occurred within 9 years of Screening Visit
  • Must have occurred when the patient was 18 years of age

Exclusion Criteria:

  • Use of antidepressant medication within 2 months of Baseline

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.